First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia
Each year, an estimated 11,000 people across the globe are diagnosed with relapsed or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (LBL). However, there is only one…